Metraipolis › archive › dc_ef67668117b4
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review — Europe PMC PMID:42345853
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42345853
- DOI
- 10.3390/antib15030049
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T09:31:01.661Z
- SHA-256 of the archived text
a6b16cbb66c793faf56f1ea390e3659b44a4e90d37bb83f226b71451ad6d332e- Stable URL of this page
https://metraipolis.com/documento/dc_ef67668117b4
How to cite
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review — Europe PMC PMID:42345853 — Europe PMC (en), https://europepmc.org/article/MED/42345853 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef67668117b4 (Metraipolis archive dc_ef67668117b4, sha256 a6b16cbb66c793faf56f1ea390e3659b44a4e90d37bb83f226b71451ad6d332e)
BibTeX
@misc{dcef67668117b4,
title = {Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review — Europe PMC PMID:42345853},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42345853},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef67668117b4; sha256 a6b16cbb66c793faf56f1ea390e3659b44a4e90d37bb83f226b71451ad6d332e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42345853. Agents can read the archived copy with the MCP tool read_document.